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Abstract
Background: Primary erythromelalgia is an autosomal dominant pain disorder characterized by
burning pain and skin redness in the extremities, with onset of symptoms during the first decade
in the families whose mutations have been physiologically studied to date. Several mutations of
voltage-gated Na+ channel NaV1.7 have been linked with primary erythromelalgia. Recently, a new
substitution NaV1.7/I136V has been reported in a Taiwanese family, in which pain appeared at later
ages (9–22 years, with onset at 17 years of age or later in 5 of 7 family members), with relatively
slow progression (8–10 years) to involvement of the hands. The proband reported onset of
symptoms first in his feet at the age of 11, which then progressed to his hands at the age of 19. The
new mutation is located in transmembrane segment 1 (S1) of domain I (DI) in contrast to all NaV1.7
mutations reported to date, which have been localized in the voltage sensor S4, the linker joining
segments S4 and S5 or pore-lining segments S5 and S6 in DI, II and III.
Results: In this study, we characterized the gating and kinetic properties of I136V mutant channels
in HEK293 cells using whole-cell patch clamp. I136V shifts the voltage-dependence of activation by
-5.7 mV, a smaller shift in activation than the other erythromelalgia mutations that have been
characterized. I136V also decreases the deactivation rate, and generates larger ramp currents.
Conclusion: The I136V substitution in NaV1.7 alters channel gating and kinetic properties. Each
of these changes may contribute to increased excitability of nociceptive dorsal root ganglion
neurons, which underlies pain in erythromelalgia. The smaller shift in voltage-dependence of
activation of NaV1.7, compared to the other reported cases of inherited erythromelalgia, may
contribute to the later age of onset and slower progression of the symptoms reported in
association with this mutation.
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Background
Voltage-gated Na+ channels are heteromeric protein com-
plexes, consisting of a pore-forming α subunit and auxil-
iary  β subunits [1]. Nine α subunits (NaV1.1–NaV1.9)
have been reported to date, and have been shown to be
expressed in a tissue-specific manner [2]. Each α subunit
is composed of four homologous domains (DI-DIV), with
each domain consisting of six transmembrane segments
(S1–S6), with S4 acting as a voltage-sensor and S5 and S6
lining the pore [1]. Voltage-gated Na+ channels are essen-
tial for the production of action potentials and are thus
pivotal for excitability of neurons, myocytes, and neu-
roendocrine cells [2]. Mutations of voltage-gated Na+
channels have been linked to a number of human diseases
including epilepsy, periodic paralysis, cardiac disorders,
and pain disorders [3-7].
Primary erythromelalgia is a rare, inherited, autosomal
dominant disorder, characterized by intermittent burning
pain in the extremities and skin redness of the affected
areas. Episodes can be triggered by warm stimuli or mild
exercise [8]. The onset of symptoms varies from child-
hood, adolescence, to adulthood [9], with onset of pain
most commonly occurring during the first decade of life.
Primary erythromelalgia has been linked to mutations in
SCN9A, the gene that encodes voltage-gated sodium chan-
nel NaV1.7 [10]. NaV1.7 is preferentially expressed in noci-
ceptive dorsal root ganglia (DRG) neurons and
sympathetic ganglia neurons [11-14], and it produces a
fast-activating and -inactivating TTX-sensitive (TTX-S) cur-
rent with a slow recovery from inactivation [12,15].
NaV1.7 also exhibits slow kinetics of closed-state inactiva-
tion, which enables it to respond to small, slow depolar-
izing inputs and boost subthreshold depolarizations [15].
Thus, gain-of-function mutations of the NaV1.7 channel
might be expected to contribute to the hyperexcitability of
nociceptive neurons which underlies chronic pain in
patients with erythromelagia.
Nine mutations of NaV1.7 have been identified in patients
with primary erythromelalgia, with eight of them, all from
families with onset in childhood (≤ 10 years of age), hav-
ing been characterized by electrophysiological studies
[16-22]. All eight mutations cause a hyperpolarizing shift
in voltage dependence of activation in NaV1.7 channels.
Slow deactivation kinetics and larger ramp currents were
observed in all but the F1449V mutant channels [16-22].
The changes in the biophysical properties of mutant
NaV1.7 are predicted to increase excitability of DRG neu-
rons and thereby contribute to the pathophysiology of
erythromelalgia. In fact, three of these mutations
(F1449V, A863P, and L858H) have been studied using
current clamp and shown to increase excitability of DRG
neurons in culture [18,20,23].
Recently, a new erythromelalgia mutation of NaV1.7 was
reported by Lee et al in a Taiwanese family, affecting fam-
ily members of three generations [24], with a later age of
onset. In this family, pain appeared first in the feet at ages
varying from 9 to 22 years, with onset at ages ≥ 17 years in
five of seven family members; pain was reported in the
hands in one-half of the affected family members, 8–10
years later (C-C Yang and M-J Lee, personal communica-
tion). The clinical phenotype was unusual in that the
proband reported onset of pain in feet at 11 years of age,
later than in most of familial cases [16,18,21,22,25] and
in the patients with de novo founder mutations that have
been studied to date [19,20]. Genetic analysis identified a
substitution of isoleucine 136 with valine (I136V) in
NaV1.7 in all affected family members, but not in unaf-
fected family members or control DNA [24]. This amino
acid substitution is located in DIS1 of the NaV1.7 channel,
in contrast to all NaV1.7 mutations reported to date,
which have been localized in the voltage sensor S4, the
linker joining segments S4 and S5 or pore-lining segments
S5 and S6 in DI, II and III. Here, we investigate the effect
of this mutation on biophysical properties of NaV1.7
channels.
Results
I136V mutation produces lower threshold for activation, 
slower kinetics of fast inactivation, and larger window 
currents
Sodium currents were recorded from HEK293 cells stably
expressing either wild type NaV1.7R  or I136V mutant
channels. Figure 1A shows representative families of
inward Na+ current traces of wild type and I136V mutant
channels. Cell capacitance was similar (p > 0.05) in cells
that were transfected with NaV1.7R or with I136V mutant
channels (NaV1.7R: 19.2 ± 0.6 pF, n = 40; I136V: 18.9 ± 0.5
pF, n = 43). Figure 1B shows the mean current-voltage
relationship of wild-type and I136V channels, with no
apparent difference of reversal potentials (NaV1.7R: 71.5 ±
0.5 mV; I136V: 70.3 ± 0.4 mV). However, currents gener-
ated by I136V mutant channels activated and reached the
maximal amplitudes at more hyperpolarized potentials
compared with wild type channels. Boltzmann fits of con-
ductance show that the I136V mutation significantly
shifted the midpoint of the activation curve in a hyperpo-
larizing direction (I136V: V1/2,act = -28.8 ± 0.5 mV, n = 43;
NaV1.7R: -23.1 ± 0.7 mV, n = 40, p < 0.05, Figure 1C, Table
1).
Activation kinetics, measured as time-to-peak, were simi-
lar between wild-type and I136V channels (Figure 1D).
The kinetics of fast inactivation, which reflects the transi-
tion from the open to inactive state, were measured by fit-
ting the decaying phase of Na+ currents in Figure 1A with
single exponential functions. Because open state inactiva-
tion is coupled to activation state [26], the curve of inacti-Molecular Pain 2008, 4:1 http://www.molecularpain.com/content/4/1/1
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I136V mutation alters voltage-dependent activation and steady-state fast inactivation of NaV1.7 channels Figure 1
I136V mutation alters voltage-dependent activation and steady-state fast inactivation of NaV1.7 channels. A, 
Representative family traces of Na+ currents from voltage-clamped HEK293 cells expressing either wild-type NaV1.7R (top) or 
I136V mutant (bottom) channels. Cells were held at -100 mV, and Na+ currents were elicited by step depolarizations from -80 
to +60 mV in 5 mV increment every 5 seconds. B, Normalized peak current-voltage relationship for NaV1.7R (n = 40) and 
I136V mutant (n = 43) channels. C, Comparison of the voltage-dependent activation and steady-state fast inactivation of 
NaV1.7R and I136V mutant channels. A hyperpolarizing shift (-5.7 mV) of activation was observed in I136V mutant channels. 
Steady-state fast inactivation was examined using a series of 500-ms prepulses from -140 mV to -10 mV followed by 40-ms test 
pulses at -10 mV. I136V mutation did not change the V1/2,fast but altered the slope factor. D, Activation kinetics, measured as 
time-to-peak, were similar between NaV1.7R and I136V mutant channels. E, Fast inactivation kinetics of NaV1.7R and I136V 
mutant channels. Inactivation time constants were calculated by fitting the decay phases of currents shown in Figure 1A with 
single-exponential function. Gray circles represent I136V shifted 5.7 mV in a depolarizing direction to match the voltage-
dependent activation of wild type NaV1.7R channels. The inactivation kinetics of I136V channels are slower than that of NaV1.7R 
channels. F, Expanded view of overlap of activation and inactivation Boltzmann fits (area as predicted window current) from C 
(shaded area for I136V mutation, and lined area for NaV1.7R).
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vation kinetics of I136V mutant channels was shifted by
5.7 mV in a depolarizing direction (gray circles in Figure
1E) to match the similar activation voltages of wild type
channels. Analysis of the data shows that the I136V sub-
stitution leads to slower kinetics of fast inactivation.
Steady-state fast inactivation was tested with a series of
500-ms prepulses from -140 to -10 mV followed by a 20
ms test pulse at -10 mV. Although mutant channels
showed less inactivation at -100 and -90 mV, no differ-
ence was observed in V1/2,fast inact between the two chan-
nels, probably because the inactivation curve of mutant
channels is steeper than that of wild type channels (Figure
1C, Table 1). Figure 1F shows the predicted window cur-
rent which is defined by the overlap of activation and
steady-state fast inactivation curves. I136V mutant chan-
nels are predicted to produce larger window currents than
wild type channels, and thus are expected to lead to a
more depolarized resting membrane potential in DRG
neurons [20,23].
I136V mutant channels exhibit slower deactivation and 
enhanced steady-state slow inactivation
Similar to most NaV1.7 mutations that cause primary
erythromelalgia, I136V mutation significantly decreases
the deactivation rate of sodium currents at all tested deac-
tivation potentials (Figure 2A). At -40 mV, the time con-
stant of deactivation was 0.22 ± 0.02 ms (n = 17) for wild
type channels and 0.94 ± 0.10 ms (n = 19) for I136V
mutant channels. Slower deactivation has been suggested
Table 1: Electrophysiological properties of wild-type and I136V mutant NaV1.7 channels.
Channel Activation Fast Inactivation Slow Inactivation Ramp Current
V1/2,act Slope n V1/2,inact Slope n V1/2,inact Slope Rin n%  o f  I max Vpeak n
NaV1.7R 23.1 ± 0.7 6.40 ± 0.14 40 82.5 ± 1.3 6.94 ± 0.15 15 -66.0 ± 1.6 13.6 ± 0.3 0.19 ± 0.02 11 0.23 ± 0.02 -42.3 ± 0.9 19
I136V 28.8 ± 0.5* 7.13 ± 0.10* 43 79.7 ± 0.6 6.00 ± 0.27* 13 -74.0 ± 0.9* 8.7 ± 0.2* 0.11 ± 0.01* 11 0.79 ± 0.04* -48.0 ± 0.5* 26
*p < 0.05, I136V vs NaV1.7R.
I136V mutation alters deactivation and steady-state slow-inactivation Figure 2
I136V mutation alters deactivation and steady-state slow-inactivation. A, Time constants of channel deactivation. 
Cells were held at -100 mV and tail currents were generated by a brief 0.5-ms depolarization to -20 mV followed by a series of 
repolarizations ranging from -100 to -40 mV to elicit tail currents (insert a). I136 mutant channels (n = 19) show significantly 
slower deactivation than NaV1.7R channels (n = 17) at all testing potentials. Insert b shows the representative tail currents from 
two HEK293 cells expressing NaV1.7R (solid line) or I136V mutant channels (dotted line). B, I136V mutation significantly 
enhances steady-state slow-inactivation. Steady-state slow-inactivation was examined by a series of prepulses (30 s) from -130 
to +10 mV followed by 100-ms return pulse to -120 mV, then a 20-ms test pulse to -10 mV.
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to contribute to neuronal excitability by prolonging
responses after the cessation of a depolarizing stimulus
[17].
Steady-state slow inactivation was enhanced in mutant
channels (Figure 2B). The V1/2,slow inact was shifted by 8 mV
in a hyperpolarizing direction, and the slope factor was
significantly reduced when compared with wild type
NaV1.7R channels. The fraction of I136V channels that are
resistant to slow inactivation was reduced compared to
wild type channels (Table 1).
I136V mutant channels recover faster from fast 
inactivation at -70 mV and generate larger ramp currents, 
compared to wild type channels
The ability of channels to recover from fast inactivation
(repriming) may determine how fast a neuron can repeti-
tively fire. Repriming kinetics of wild type and mutant
channels were examined for a series of recovery periods at
four different recovery potentials between prepulses and
test pulses. I136V mutation does not change the reprim-
ing kinetics at -100, -90, and -80 mV, but significantly
enhances the recovery at -70 mV (Figure 3A).
The responses of wild type and mutant channels to slow
ramp depolarizations were also tested. HEK293 cells
expressing mutant channels produced larger ramp cur-
rents than cells expressing wild type channels (I136V:
0.79 ± 0.04%, n = 26; WT: 0.23 ± 0.02%, n = 19, p < 0.05).
The I136V mutation also shifted the onset of the currents
to more negative potentials (I136V: -48.0 ± 0.5 mV, n =
26; WT: -42.3 ± 0.9 mV, n = 19, p < 0.05).
Discussion
In this study we investigated the gating properties of the
I136V mutation of NaV17 channels, which has been
linked to inherited primary erythromelalgia in a Taiwan-
ese family reported by Lee et al [24]. Compared to wild-
type channels, the I136V substitution leads to a hyperpo-
larizing shift of activation, slower deactivation kinetics,
and larger ramp currents. The I136V mutation did not
alter voltage-dependent steady-state fast-inactivation, but
decreased the slope factor. The significant changes in the
I136V mutation alters recovery from fast-inactivation and increases currents elicited by slow ramp depolarizations Figure 3
I136V mutation alters recovery from fast-inactivation and increases currents elicited by slow ramp depolariza-
tions. A, Cells were held at -100 mV, and fast-inactivation was initiated by a 20-ms depolarization to 0 mV, followed by a 
recovery period (2–300 ms) at a recovery potential, followed by a 10-ms test pulse to 0 mV to measure the available channels. 
Recovery rate were calculated by comparing the peak currents of test pulse to prepulse at 0 mV (20 ms) after various recovery 
durations (2–300 ms) at different recovery potentials (-100, -90, -80, and -70 mV), and plotted as a function of recovery poten-
tials. Recovery time constants of NaV1.7R and I136V mutant channels were then estimated using single-exponential fits. At a 
recovery potential of -70 mV, I136V mutant channels (n = 11) recovered faster than wild type NaV1.7R channels (n = 12). B, 
Representative ramp currents from NaV1.7R (black) and I136V mutant (gray) channels. HEK293 cells were held at -100 mV and 
a depolarizing voltage ramp from -100 mV to +20 mV was applied at a rate of 0.2 mV/ms. The insert shows mean ramp cur-
rents of wild type NaV1.7R and I136V mutant channels. Currents were normalized to the maximal peak currents from step 
depolarizations in Figure 1B. I136V mutant channels were activated at more negative potentials and generated larger ramp cur-
rents than NaV1.7R channels (NaV1.7R: 0.23 ± 0.02, n = 19; I136V: 0.79 ± 0.04, n = 26, p < 0.05).
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slopes of the activation and steady-state inactivation
Boltzman fits might be due to altered allosteric interac-
tions among the four voltage sensor domains. Mutant
channels also reprimed faster than wild-type channels but
only at a recovery voltage of -70 mV. These changes of the
biophysical properties of NaV1.7 are expected to contrib-
ute to hyperexcitability of DRG neurons, which underlies
painful symptoms of erythromelalgia.
I136V mutant channels significantly enhanced slow-inac-
tivation which would be expected to reduce excitability of
DRG neurons. However, enhanced slow inactivation has
been reported in other erythromelalgia mutations, sug-
gesting that enhanced voltage-dependence of NaV1.7 acti-
vation dominates over slow inactivation in these
erythromelalgia mutations [17,21]. Computer simula-
tions of the effect of mutant NaV1.7 channels in model
DRG neurons have in fact shown that the hyperpolarized
shift in the activation of channels is the key factor in
inducing neuron hyperexcitability, whereas slow inactiva-
tion modulates the effect on the firing frequency of these
neurons [22].
The location (DIS1) and conservative nature of the I136V
substitution might account for the milder effect of this
mutation on the channel gating properties. Among the
eight erythromelalgia mutations characterized so far, four
are located within the S4–S5 linkers of DI [21] or DII
[17,19], one in DIS4 [16], one each in DIS6 [22] and
DIIIS6 [18], and one in DIIS5 [20]. Considering the
importance of these regions for channel function [1], it is
not surprising that those mutations alter NaV1.7 activity.
In contrast, I136V is located within DIS1, a segment
which has not been shown to have a dominant effect in
channel gating. Moreover, both Val and Ile are neutral,
nonpolar branched amino acids which differ by a single
methyl group in their side chain, and substitution of one
residue by the other is generally not expected to cause sig-
nificant change in protein function. However, a similarly
conservative substitution of a serine with threonine
(S241T) in the DI S4–S5 linker [27] has been proven to
have a significant effect on channel activation, an effect
which is likely caused by the larger side chain of the thre-
onine residue compared to that of serine [21]. Thus, the
I136V substitution might influence the packing of the S1
segment within the voltage sensor domain (S1–S4) [28]
and this could lead to altered gating properties by favoring
the open state of the channel.
The conservation of an isoleucine in DIS1 of most voltage-
gated sodium and calcium channels is consistent with a
role of this residue in channel function. A recent study
identified a conserved motif (F-XXX-I-XXX-I-XX-N/S-XXX-
M/L; the residue in boldface corresponds to I136 in
NaV1.7) within S1 segments of most voltage-gated Na+
and Ca2+ channels [29]. However, NaV1.9 is an exception
because the residue which corresponds to I136 in DIS1 is
valine [30-32], similar to the mutant NaV1.7 from the Tai-
wanese family [24]. NaV1.9 activates at more hyperpolar-
ized potentials compared to the other sodium channels
[31,33], and while the S1 sequence of NaV1.9 carries addi-
tional amino acid changes compared to the other chan-
nels, it is possible that the equivalent residue of NaV1.7/
I136 within NaV1.9 contributes to the hyperpolarized
activation of this channel. Interestingly, M145T in DIS1 in
NaV1.1 (which corresponds to the last conserved residue
in the S1 consensus motif) has been linked to familial
febrile seizures and the activation curve of the mutant
NaV1.1 has been reported to shift by 10 mV in a depolar-
izing direction [34]. The opposite effects on voltage-
dependence of channel activation of I136V and M145T
could reflect a fundamental difference in the structure of
the voltage sensor domain (S1–S4) as a consequence of
conservative (I136V) and non-conservative (M145T) sub-
stitutions of key residues in S1.
The mutation I136V causes a smallest shift (-5.7 mV) in
voltage-dependent activation compared to the other
erythromelalgia mutations that have been studied to date
[16-22]. The small shift induced by I136V is possibly
related to the location of the mutation within DIS1 and
the conservative nature of the substitution, but despite the
reduced magnitude of the shift in I136V, it appears to be
enough to contribute to the erythromelalgia symptoms. It
is possible that the smaller shift in channel activation is a
factor that contributes to the later onset and relatively
slower progression of the symptoms from feet to hands in
this family. This case may thus represent a correlation of
genotype and phenotype in patients with primary eryth-
romelalgia.
Recent studies have revealed an association between mis-
sense mutations within other parts of NaV1.7 and another
painful neuropathy, paroxysmal extreme pain disorder
(PEPD) [35], whereas nonsense mutations of NaV1.7 have
been linked to channelopathy-associated congenital
indifference to pain [36-38]. The identification and char-
acterization of mutant NaV1.7 channels have begun to
elucidate the molecular basis for positive symptoms
(pain) and negative symptoms (indifference to pain) in
patients carrying these mutations. The present results doc-
ument another gain-of-function mutation of NaV1.7 that
is associated with painful symptoms in humans, in a fam-
ily with onset of erythromelalgia's symptoms in the sec-
ond decade, and add to the data pointing to this channel
as a target for therapeutic intervention for the treatment of
chronic pain.Molecular Pain 2008, 4:1 http://www.molecularpain.com/content/4/1/1
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Conclusion
I136V mutation in DIS1 of NaV1.7 channels has been
reported to cause primary erythromelalgia in a Taiwanese
family, with onset of symptoms in the second decade.
Electrophysiological study revealed a hyperpolarizing
shift of the voltage-dependence of activation, decreased
deactivation rate, and a larger response to slow ramp
depolarization in mutant channels. All these changes
could contribute to the development of primary eryth-
romelalgia. The shift in activation is smaller when com-
pared with other primary erythromelalgia mutations
which present with pain at earlier ages, possibly due to the
conservative nature of the substitution between isoleucine
and valine and the location of this mutation in the DIS1
in NaV1.7. This study adds to the evidence for an essential
role of NaV1.7 in the pain sensory pathway, and suggests
that the extent of shift of voltage-dependence of activation
of NaV1.7 may be a factor that is correlated with the rate
of development of erythromelalgia symptoms.
Methods
Plasmids and stable cell lines
The TTX-resistant human NaV1.7R expression vector has
been described previously [39]. The I136V substitution
was introduced into NaV1.7R using the QuickChange XL
site-directed mutagenesis kit (Stratagene, La Jolla, CA).
Human embryonic kidney cells (HEK293) stably express-
ing either wild-type (NaV1.7R) or mutant (I136V) chan-
nels were generated as described before [21].
Electrophysiology
Whole-cell voltage-clamp recordings of HEK293 cells
expressing either wild type NaV1.7R  or I136V mutant
channels were performed at room temperature
(20–22°C) using an Axopatch 200 B amplifier (Axon
Instruments, Foster City, CA). Fire-polished electrodes
(0.6–1.3 MΩ) were fabricated from 1.6 mm outer diame-
ter borosilicate glass micropipettes (World Precision
Instruments, Sarasota, FL). The pipette potential was
adjusted to zero before seal formation, and liquid junc-
tion potential was not corrected. Capacity transients were
cancelled and voltage errors were minimized with
80–90% series resistance compensation. Currents were
acquired with Clampex 9.2, 5 min after establishing
whole-cell configuration, sampled at a rate of 50 or 100
kHz, and filtered at 10 kHz.
For current-voltage relationships, cells were held at -100
mV and stepped to a range of potentials (-80 to +60 mV in
5 mV increments) for 50 ms. Peak inward currents (I)
were plotted as a function of depolarization potential to
generate I-V curves. Activation curves were obtained by
converting I to conductance (G) at each voltage (V) using
the equation G  =  I/(V-Vrev), where Vrev is the reversal
potential which was determined for each cell individually.
Activation curves were then fit with Boltzmann function
in the form of G = Gmax/{1 + exp[(V1/2,act-V)/k]}, where
Gmax is the maximal sodium conductance, V1/2,act is the
potential at which activation is half-maximal, V is the test
potential, and k is the slope factor.
Steady-state fast inactivation was achieved with a series of
500-ms prepulses (-140 to 10 mV in 10 mV increments)
and the remaining non-inactivated channels were acti-
vated by a 20 ms step depolarization to -10 mV. Steady-
state slow inactivation was determined with 30 s pre-
pulses ranging from -130 to +10 mV followed by a 100 ms
hyperpolarization at -120 mV to remove fast inactivation.
Remaining available channels were activated by a 20 ms
test pulse to -10 mV. Peak inward currents obtained from
steady-state fast inactivation and slow inactivation proto-
cols were normalized with the maximal peak current
(Imax) and fit with Boltzman functions:
I/Imax = 1/{1 + exp[(V - V1/2,inact)/k]}
for fast inactivation, and
I/Imax = Rin + (1 - Rin)/{1 + exp[(V - V1/2,inact)/k]}
for slow inactivation, where
V represents the inactivating prepulse potential, V1/2,inact
represents the midpoint of inactivation curve, and Rin is
the fraction of channels that are resistant to inactivation.
Deactivation was examined using a short (0.5 ms) depo-
larizing pulse to -20 mV followed by a 50 ms repolarizing
pulse to potentials ranging from -100 to -40 mV with 5
mV increments. Deactivation kinetics was calculated by
fitting the decaying currents with a single exponential
function. Ramp currents were elicited with a slow depolar-
izing voltage ramp from -100 to +20 mV at a rate of 0.2
mV/ms. The absolute ramp current amplitude was nor-
malized to the maximal peak current obtained by I-V pro-
tocol.
The pipette solution contained (in mM): 140 CsF, 10
NaCl, 1 EGTA, 10 dextrose, and 10 HEPES, pH 7.35
(adjusted with CsOH), and the osmolarity was adjusted to
307 mOsmol/L with sucrose. The extracellular bath solu-
tion contained (in mM): 140 NaCl, 3 KCl, 1 MgCl2, 1
CaCl2, 10 dextrose, 10 HEPES, pH 7.4 (adjusted with
NaOH), and the osmolarity was adjusted to 311 mOs-
mol/L with sucrose. Tetrodotoxin (TTX, 300 nM) was
added to the bath solution to block endogenous voltage-
gated sodium currents in HEK293 cells, permitting cur-
rents from wild type NaV1.7R or I136V to be recorded in
isolation.Molecular Pain 2008, 4:1 http://www.molecularpain.com/content/4/1/1
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Data Analysis
Data were analyzed using Clampfit 9.2 (Molecular
Devices) and Origin 7.5 (Microcal Software, Northamp-
ton, MA), and presented as means ± SE. Statistical signifi-
cance was determined by unpaired student's t tests.
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